India MCA Corporate Compliance Enforcement — May 30, 2026
The batch of six India MCA/SEBI compliance filings from May 29-30, 2026, reveals a polarized corporate governance landscape: routine procedural compliance is overshadowed by material regulatory violations and sharp financial deterioration. A notable positive outlier is **Gandhar Oil Refinery**, which secured a ₹17.69 Cr customs refund, a one-time windfall that will augment working capital. Conversely, **Genesys International** was fined ~₹4.2L by both exchanges for board composition non-compliance (Reg 17(1)), highlighting ongoing governance gaps in tech-driven firms. **Vivo Bio Tech Ltd** is the highest-risk name, swinging from a ₹125.83 Lakh profit in Q3 FY26 to a ₹543.69 Lakh net loss in Q4 FY26, driven by a massive ₹696.95 Lakh deferred tax charge and despite a 3% QoQ revenue increase. **DCM Shriram Fine Chemicals** passed all 12 postal ballot resolutions with >98% shareholder approval, indicating strong board stability. Period-over-period comparisons show mixed quality of earnings: revenue growth at Vivo Bio (3% QoQ standalone) is being wiped out by non-cash charges, while Ashoka Refineries and DCM Shriram filings are purely procedural with zero financial disclosure. Insider activity and forward-looking guidance are notably sparse across this batch, limiting management conviction signals.